Omeros (OMER) announced statistical sensitivity analysis results related to the primary endpoint analysis for narsoplimab, Omeros’ monoclonal ...
Omeros Corporation (Nasdaq: OMER) today announced statistical sensitivity analysis results related to the primary endpoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback